Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies

Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus

(2013) Eliano Pio Navarese et al.   AMERICAN JOURNAL OF CARDIOLOGY

Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients

(2013) Maki Miyamoto-Sasaki et al.   Journal of Atherosclerosis and Thrombosis

Risk of incident diabetes among patients treated with statins: population based study

(2013) A. A. Carter et al.   BMJ-British Medical Journal

Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance

(2012) J. Boon et al.   DIABETES

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

(2012) Paul M Ridker et al.   LANCET

The emerging role of HDL in glucose metabolism

(2012) Brian G. Drew et al.   Nature Reviews Endocrinology

Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia

(2012) Steen Stender et al.   European Journal of Preventive Cardiology

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

(2012)   European Journal of Preventive Cardiology

Long-term efficacy of pitavastatin versus simvastatin

(2011) Mats Eriksson et al.   ADVANCES IN THERAPY

Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial

(2011) Mats Eriksson et al.   ADVANCES IN THERAPY

Are statins diabetogenic?

(2011) Uchechukwu K Sampson et al.   CURRENT OPINION IN CARDIOLOGY

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia

(2011) J. Gumprecht et al.   DIABETES OBESITY & METABOLISM

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

(2011) David Preiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

(2011) David D. Waters et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia

(2009) Leiv Ose et al.   ATHEROSCLEROSIS

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis

(2009) William L. Baker et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug–drug interaction with statins

(2008) Alberto Corsini et al.   Expert Review of Clinical Pharmacology